Changjiang Runfa Health Industry Co., Ltd.

    Changjiang Runfa Health Industry Co., Ltd.

    SSZSE:002435
    0.37
    CNY
    -0.02
    (-5.13%)
    88.44P/E
    2011 Y
    2012 Y
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    TTM
    Revenue per Share
    2.23
    3.47
    2.28
    2.4
    2.13
    2.49
    2.38
    3.78
    4.07
    3.43
    3.54
    2.8
    2.62
    2.43
    Basic EPS, GAAP
    0.09
    0.13
    0.1
    0.09
    0.09
    0.19
    0.27
    0.3
    -0.31
    0.2
    -0.33
    0.05
    -0.62
    -0.67
    Free Cash Flow per Basic Share
    -0.35
    0.12
    -0.18
    -0.04
    -0.12
    0.6
    0.31
    0.15
    0.22
    0.1
    0.16
    0.28
    0.12
    -0.16
    Dividend per Share
    0.06
    0.1
    0.06
    0.07
    0.09
    0.05
    0.05
    0.23
    0.12
    0.06
    0.12
    0.05
    0.06
    0.2
    Book Value per Share
    0.5
    0.83
    0.75
    0.79
    0.84
    0.99
    0.9
    1.25
    1.19
    1.39
    0.87
    0.92
    0.3
    0.29
    Tangible Book Value per Share
    1.31
    2.05
    1.39
    1.44
    7.73
    3.44
    2.56
    2.08
    2.38
    2.35
    2.48
    2.48
    2.27
    2.25
    Basic Weighted Avg Shares
    503
    338
    506
    511
    499
    851
    1,255
    1,236
    1,237
    1,236
    1,236
    1,237
    1,236
    1,243
    Sales/Revenue/Turnover
    1,120
    1,175
    1,155
    1,228
    1,065
    2,115
    2,987
    4,674
    5,038
    4,241
    4,370
    3,470
    3,238
    3,025
    Operating Margin (%)
    5.82
    5.77
    6.84
    6.37
    7.36
    17.12
    13.46
    11.65
    10.01
    10.78
    6.25
    5.42
    -0.13
    -2.94
    Depreciation Expense
    23
    26
    34
    41
    43
    84
    105
    126
    149
    130
    139
    148
    184
    - -
    Net Income, GAAP
    46
    42
    52
    48
    43
    160
    335
    367
    -383
    248
    -413
    65
    -767
    -837
    Effective Tax Rate (%)
    17.71
    17.68
    17.93
    15.61
    13.43
    14.94
    12.55
    19.17
    - -
    16.21
    - -
    37.73
    - -
    47.44
    Profit Margin (%)
    4.11
    3.61
    4.47
    3.92
    4.05
    7.57
    11.21
    7.86
    -7.59
    5.84
    -9.45
    1.88
    -23.68
    -27.67
    Working Capital
    442
    317
    268
    284
    3,350
    1,823
    2,044
    1,926
    2,197
    1,823
    2,079
    1,465
    1,077
    1,029
    LT Debt
    - -
    - -
    - -
    - -
    44
    17
    - -
    436
    436
    492
    475
    309
    527
    472
    Total Equity
    761
    790
    829
    857
    3,980
    5,064
    5,343
    5,657
    5,173
    5,107
    4,607
    4,650
    3,769
    3,753
    Return on Invested Capital (%)
    5.59
    5.53
    6.19
    5.82
    2.43
    6.28
    6.18
    6.8
    - -
    6.02
    - -
    1.87
    - -
    - -
    Return on Capital (%)
    11.21
    11.56
    11.39
    9.32
    4.15
    2.1
    24.45
    15.51
    - -
    10.22
    - -
    4.72
    - -
    2.44
    Return on Common Equity (%)
    19.25
    15.9
    15.64
    12.28
    10.45
    25.32
    33.93
    27.51
    -25.37
    15.48
    -29.48
    5.87
    -101.02
    -106.74

    Capital Structure

    CNY

    •

    in mil. unless spec.
    Sep'23
    Dec'23
    Mar'24
    ST Debt
    1,797
    1,878
    1,811
    LT Borrowings
    202
    404
    312
    LT Finance Leases
    140
    123
    160
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    1,236
    1,236
    1,236
    Market Capitalization
    5,742
    5,150
    3,903

    Working Capital

    CNY

    •

    in mil. unless spec.
    Sep'23
    Dec'23
    Mar'24
    Total Current Assets
    4,389
    5,266
    5,143
    Cash, Cash Equivalents & STI
    3,082
    2,691
    799
    Accounts Receivable, Net
    290
    265
    273
    Inventories
    624
    579
    546
    Total Current Liabilities
    2,776
    4,189
    4,114
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    1,797
    1,878
    1,811
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CNY

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    36.87%
    -7.53%
    -18.94%
    Free Cash Flow
    -83.27%
    14.85%
    -57.59%
    Net Income, GAAP
    -165.44%
    -405.53%
    -1,276.14%
    Sales/Revenue/Turnover
    15.71%
    -6.45%
    -6.67%
    Total Cash Common Dividend
    39.28%
    -5.01%
    16.52%

    Quarterly Revenue

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    905
    894
    952
    719
    3,470
    2023
    874
    875
    784
    706
    3,238
    2024
    660
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    0.05
    - -
    - -
    - -
    0.05
    2023
    0.05
    - -
    - -
    - -
    -0.62
    2024
    -0.01
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    0.01
    - -
    - -
    - -
    0.05
    2023
    0.01
    - -
    - -
    - -
    0.06
    2024
    0.15
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business